Back to Results

Westleaf Inc (DBCCF)

Westleaf Inc, listed on OTC Markets under the symbol DBCC.F, is identified as a common equity security. The available company description refers to Decibel Cannabis Company Inc., an integrated cannabis business based in Calgary, Canada. Its operations include cultivating, processing, and selling cannabis flower in Canada, along with the extraction, manufacturing, and sale of derivative products such as vapes, cannabis-infused pre-rolls, pre-rolls, edibles, and other value-added items. The company also conducts business-to-business sales in Saskatchewan and Alberta and serves e-commerce end customers in Saskatchewan. Its products are marketed under the Qwest, Vox, Blendcraft, and General Admission brands.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-DBCC.F
$1.18
-15.4% Downside
Fair
Not available
Not available
Good
0.0%
November 12, 2026
1.1x
0.6x
53.427 M
84.436 M
92.3%
74.2%
6.0
715.3%
Valuation • Fair Value

Westleaf Inc (OTC-DBCC.F) Fair Value by Valuation Model

Review the available estimates for Westleaf Inc (OTC-DBCC.F), including EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$1.18

Estimated downside of 15.4% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

EPV Fair Value

$0.72

Earnings power value estimate.

Comps Fair Value

$1.26

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 4 available valuation references for Westleaf Inc (OTC-DBCC.F) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Westleaf Inc (OTC-DBCC.F)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

89.6 M

Current operating scale indicator.

Revenue Forecast

97.993 M

Forward revenue estimate.

EBITDA

7.523 M

Current operating profitability reference.

EBITDA Forecast

21.846 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Westleaf Inc (OTC-DBCC.F) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Westleaf Inc (OTC-DBCC.F)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

3

Weak quality score that deserves closer review.

Beneish M-Score

-1.78

Intermediate zone that deserves monitoring.

Altman Z-Score

6.0

Relatively strong balance-sheet zone.

FCF / Net Income

715.3%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Westleaf Inc (OTC-DBCC.F). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Westleaf Inc (OTC-DBCC.F)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 12, 2026

Days to Earnings

71

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Westleaf Inc (OTC-DBCC.F), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Westleaf Inc (OTC-DBCC.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Westleaf Inc (OTC-DBCC.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Westleaf Inc (OTC-DBCC.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Westleaf Inc (OTC-DBCC.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Westleaf Inc (OTC-DBCC.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Westleaf Inc (OTC-DBCC.F) Stock FAQ

Data-supported answers about Westleaf Inc (OTC-DBCC.F), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$1.18
Estimated downside 15.4%
Valuation Rating
Overvalued
Estimated downside of 15.4%
Financial Health
Good
Current financial-health read

The current fair value estimate for Westleaf Inc (OTC-DBCC.F) is $1.18. This implies an estimated downside of 15.4% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 15.4% versus the current market price.

The current financial health read for Westleaf Inc (OTC-DBCC.F) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Westleaf Inc (OTC-DBCC.F) is November 12, 2026.

The latest available data indicates no current dividend yield for Westleaf Inc (OTC-DBCC.F).

The current market capitalization listed for Westleaf Inc is 53.427 M.

The current enterprise value listed for Westleaf Inc is 84.436 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Westleaf Inc is OTC-DBCC.F, and the stock is listed on OTC Markets.

Westleaf Inc (OTC-DBCC.F) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Westleaf Inc is 92.3%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Westleaf Inc is 74.2%. Free float helps investors understand how much of the share base is available for public trading.

Similar Pharmaceuticals Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

LLY NYSE Eli Lilly and Company Fair Value Fair Market Cap 1,043 B
JNJ NYSE Johnson & Johnson Fair Value Fair Market Cap 648.7 B
MRK NYSE Merck & Company Inc Fair Value Fair Market Cap 372.3 B
NVS NYSE Novartis AG ADR Fair Value Fair Market Cap 269.8 B
NVO NYSE Novo Nordisk A/S Fair Value Bargain Market Cap 175.3 B
PFE NYSE Pfizer Inc Fair Value Fair Market Cap 159.2 B
BMY NYSE Bristol-Myers Squibb Company Fair Value Fair Market Cap 127.2 B
SNY NASDAQ Sanofi ADR Fair Value Undervalued Market Cap 102 B
GSK NYSE GSK plc DRC Fair Value Undervalued Market Cap 101.9 B
TAK NYSE Takeda Pharmaceutical Co Ltd ADR Fair Value Fair Market Cap 60.536 B
TEVA NYSE Teva Pharma Industries Ltd ADR Fair Value Fair Market Cap 46.053 B
HLN NYSE HALEON PLC ADR Fair Value Fair Market Cap 40.268 B
RPRX NASDAQ Royalty Pharma Plc Fair Value Fair Market Cap 33.639 B
ZTS NYSE Zoetis Inc Fair Value Bargain Market Cap 30.107 B
VTRS NASDAQ Viatris Inc Fair Value Undervalued Market Cap 19.733 B
JAZZ NASDAQ Jazz Pharmaceuticals PLC Fair Value Fair Market Cap 15.616 B
CORT NASDAQ Corcept Therapeutics Incorporated Fair Value Overvalued Market Cap 12.702 B
ELAN NYSE Elanco Animal Health Fair Value Fair Market Cap 11.456 B
AXSM NASDAQ Axsome Therapeutics Inc Fair Value Fair Market Cap 10.639 B
RDY NYSE Dr. Reddy’s Laboratories Ltd ADR Fair Value Fair Market Cap 10.564 B